Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-25
1997-12-16
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514292, 544333, 544405, 546 84, 546285, C07D40104, C07D40304, A61K 3144, A61K 31505
Patent
active
056985592
ABSTRACT:
Compounds of Formula I have been shown to enhance the release of the neurotransmitter acetylcholine, and thus may be useful in the treatment of diseases of man, such as in Alzheimer's disease and other conditions involving learning and cognition, where subnormal levels of this neurochemical are found.
The compounds of this invention can be described as shown in Formula I ##STR1## where Q is ##STR2## R.sup.1 is 4-, 3-, or 2-pyridyl, pyrimidyl, pyrazinyl, or fluoro-4-pyridyl;
REFERENCES:
patent: 4760083 (1988-07-01), Myers et al.
patent: 5173489 (1992-12-01), Earl et al.
Teleha Christopher Allan
Wilkerson Wendell Wilkie
Boudreaux Gerald J.
Rotman Alan L.
The DuPont Merck Pharmaceutical Company
Vance David H.
LandOfFree
Disubstituted polycyclic systems as cognition enhancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Disubstituted polycyclic systems as cognition enhancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disubstituted polycyclic systems as cognition enhancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206396